Advisory Committee on Immunization Practices: Teleconference, 31193 [E6-8590]

Download as PDF Federal Register / Vol. 71, No. 105 / Thursday, June 1, 2006 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee on Immunization Practices: Teleconference Dated: May 26, 2006. Diane Allen, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–8590 Filed 5–31–06; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Name: Advisory Committee on Immunization Practices (ACIP) teleconference. Time and Date: 10 a.m.—11 a.m., June 8, 2006. Place: The conference call will originate at the National Immunization Program (NIP), in Atlanta. Georgia. Please see SUPPLEMENTARY INFORMATION for details on accessing the conference call. Status: Open to the public, limited only by the availability of telephone ports. Purpose: The Committee is charged with advising the Director, CDC, on the appropriate uses of immunizing agents. In addition, under 42 U.S.C. 1396s, the Committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children (VFC) program, along with schedules regarding the appropriate periodicity, dosage, and contraindications applicable to the vaccines. Matters to Be Discussed: To discuss background for decisions about the use of tetanus, reduced diphtheria and acellular (Tdap) vaccine in pregnant women. wwhite on PROD1PC61 with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announce the following Federal Committee meeting. National Institute for Occupational Safety and Health (NIOSH); Advisory Board on Radiation and Worker Health (ABRWH) Supplementary Information: This conference call is scheduled to begin at 10 a.m., Eastern Standard Time. To participate in the conference call, please dial 1–888–710–9649 and reference passcode 4003357. As provided under 41 CFR 102– 3.150(b), the public health urgency of this agency business requires that the meeting be held prior to the first available date for publication of this notice in the Federal Register. For Further Information Contact: Demetria Gardner, Epidemiology and Surveillance Division, National Immunization Program, CDC, 1600 Clifton Road, NE, (E–05), Atlanta, Georgia 30333, telephone 404/639– 8836, fax 404/639–8616. The Acting Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. VerDate Aug<31>2005 19:10 May 31, 2006 Jkt 208001 Centers for Disease Control and Prevention In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention announces the following committee meeting: Name: Advisory Board on Radiation and Worker Health, National Institute for Occupational Safety and Health and Subcommittee for Dose Reconstruction and Site Profile Reviews (SDRSPR). Subcommittee Meeting Time and Date: 9 a.m.–12 p.m., June 14, 2006. Committee Meeting Times and Dates: 1 p.m.–5:45 p.m., June 14, 2006. 8:30 a.m.–6:15 p.m., June 15, 2006. 8:30 a.m.–5 p.m., June 16, 2006. Public Comment Times and Dates: 4:15 p.m.–5:45 p.m., June 14, 2006. 1 p.m.–1:30 p.m., June 15, 2006. 5 p.m.–6:15 p.m., June 15, 2006. Place: Marriott Metro Center, 775 12th Street, Washington, DC 20005. Phone 202.737.2200, Fax 202.347.5886. Status: Open to the public, limited only by the space available. The meeting space accommodates approximately 75 people. Background: The ABRWH was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Board include providing advice on the development of probability of causation guidelines which have been promulgated by the Department of Health and Human Services (HHS) as a final rule, advice on methods of dose reconstruction which have also been promulgated by HHS as a final rule, advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program, and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Board to HHS, which subsequently delegated this authority to the CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, renewed at appropriate intervals, and will expire on August 3, 2007. PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 31193 Purpose: This board is charged with (a) Providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advise the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. Matters To Be Discussed: The agenda for the Subcommittee meeting includes Selection of 6th Round of Individual Dose Reconstruction (DR) Cases; Completion of Review of 2nd and 3rd Round of DR Cases; and Completion of Procedures Review. The agenda for the Board meeting includes NIOSH and DOL Program Status Updates; Conflict of Interest; Ames SEC Petition; NIOSH Presentation on Partial Dose Reconstructions for Non-Presumtive Cancers Added to the SEC; Status and Planning for Upcoming SEC Petitions: Allied Chemical, S–50, LANL, and Harshaw; Discussion of Board’s Use of Subcommittees and Working Groups; SC&A Report of SEC Review Procedures; SEC Petition Updates for Y–12, Rocky Flats, Nevada Test Site and Pacific Proving Ground; Site Profile Updates for: Savannah River Site, Hanford, and Nevada Test Site; Second Year Site Profiles; Finalization of Selection of 6th Round of Individual DR Cases; SC&A Initial Presentation of 4th Round of DR Cases; Finalization of Review of the 2nd and 3rd Rounds of Individual DR Cases; and Finalization of Report on Procedures Review; NIOSH Update on Program Issues: Bethlehem Steel Site Profile, Construction Workers, Site Profile Revision Activities, Quality Assurance/Quality Control, and Communications Initiative; Future Plans and Schedules. The agenda is subject to change as priorities dictate. In the event an individual cannot attend, written comments may be submitted. Any written comments received will be provided at the meeting and should be submitted to the contact person below well in advance of the meeting. For More Information Contact: Dr. Lewis V. Wade, Executive Secretary, NIOSH, CDC, 4676 Columbia Parkway, Cincinnati, Ohio 45226, telephone 513.533.6825, fax 513.533.6826. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: May 24, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. FR Doc. E6–8586 Filed 5–31–06; 8:45 am] BILLING CODE 4163–19–P E:\FR\FM\01JNN1.SGM 01JNN1

Agencies

[Federal Register Volume 71, Number 105 (Thursday, June 1, 2006)]
[Notices]
[Page 31193]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-8590]



[[Page 31193]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices: Teleconference

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announce the following Federal Committee meeting.

    Name: Advisory Committee on Immunization Practices (ACIP) 
teleconference.
    Time and Date: 10 a.m.--11 a.m., June 8, 2006.
    Place: The conference call will originate at the National 
Immunization Program (NIP), in Atlanta. Georgia. Please see 
SUPPLEMENTARY INFORMATION for details on accessing the conference 
call.
    Status: Open to the public, limited only by the availability of 
telephone ports.
    Purpose: The Committee is charged with advising the Director, 
CDC, on the appropriate uses of immunizing agents. In addition, 
under 42 U.S.C. 1396s, the Committee is mandated to establish and 
periodically review and, as appropriate, revise the list of vaccines 
for administration to vaccine-eligible children through the Vaccines 
for Children (VFC) program, along with schedules regarding the 
appropriate periodicity, dosage, and contraindications applicable to 
the vaccines.
    Matters to Be Discussed: To discuss background for decisions 
about the use of tetanus, reduced diphtheria and acellular (Tdap) 
vaccine in pregnant women.
    Supplementary Information: This conference call is scheduled to 
begin at 10 a.m., Eastern Standard Time. To participate in the 
conference call, please dial 1-888-710-9649 and reference passcode 
4003357.
    As provided under 41 CFR 102-3.150(b), the public health urgency of 
this agency business requires that the meeting be held prior to the 
first available date for publication of this notice in the Federal 
Register.
    For Further Information Contact: Demetria Gardner, Epidemiology and 
Surveillance Division, National Immunization Program, CDC, 1600 Clifton 
Road, NE, (E-05), Atlanta, Georgia 30333, telephone 404/639-8836, fax 
404/639-8616.
    The Acting Director, Management Analysis and Services Office, has 
been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: May 26, 2006.
Diane Allen,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
 [FR Doc. E6-8590 Filed 5-31-06; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.